SkinHealth Systems Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period
SkinHealth Systems Inc. (SKIN) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period of 20.00 thousand shares for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Notes › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod · last filed 2026-08-06
- SkinHealth Systems Inc. share-based compensation arrangement by share-based payment award, options, expirations in period for the quarter ending 2026-06-30 was 20.00K shares, a 90.68% decline year-over-year.
- SkinHealth Systems Inc. share-based compensation arrangement by share-based payment award, options, expirations in period for the quarter ending 2026-03-31 was 0.00 shares, a 100.00% decline year-over-year.
- SkinHealth Systems Inc. share-based compensation arrangement by share-based payment award, options, expirations in period for the quarter ending 2025-12-31 was 80.92K shares.
- SkinHealth Systems Inc. share-based compensation arrangement by share-based payment award, options, expirations in period for the quarter ending 2025-09-30 was 387.00K shares.
- SkinHealth Systems Inc. share-based compensation arrangement by share-based payment award, options, expirations in period for fiscal 2025 was 948.67K shares, a 782.90% increase from fiscal 2024.
- SkinHealth Systems Inc. share-based compensation arrangement by share-based payment award, options, expirations in period for fiscal 2024 was 107.45K shares, a 73.62% decline from fiscal 2023.
- SkinHealth Systems Inc. share-based compensation arrangement by share-based payment award, options, expirations in period for fiscal 2023 was 407.31K shares, a 730.40% increase from fiscal 2022.
- SkinHealth Systems Inc. share-based compensation arrangement by share-based payment award, options, expirations in period for fiscal 2022 was 49.05K shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period 12 month |
|---|---|---|---|---|
| 2026-06-30 | 20.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | 20.00K shares 10-Q · filed 2026-08-06 | 100.92K shares derived: sum of 3 quarters · filed 2026-08-06 | 487.93K shares derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | 0.00 shares 10-Q · filed 2026-05-07 | 80.92K shares derived: sum of 2 quarters · filed 2026-05-07 | 467.93K shares derived: sum of 3 quarters · filed 2026-05-07 | 682.42K shares derived: sum of 4 quarters · filed 2026-05-07 |
| 2025-12-31 | 80.92K shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | 467.93K shares derived: sum of 2 quarters · filed 2026-03-12 | 682.42K shares derived: sum of 3 quarters · filed 2026-03-12 | 948.67K shares 10-K · filed 2026-03-12 |
| 2025-09-30 | 387.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | 601.50K shares derived: sum of 2 quarters · filed 2025-11-06 | 867.75K shares 10-Q · filed 2025-11-06 | |
| 2025-06-30 | 214.50K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | 480.75K shares 10-Q · filed 2025-08-07 | ||
| 2025-03-31 | 266.25K shares 10-Q · filed 2025-05-08 | |||
| 2024-12-31 | 107.45K shares 10-K · filed 2025-03-12 | |||
| 2023-12-31 | 407.31K shares 10-K · filed 2024-03-12 | |||
| 2022-12-31 | 10.00K shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01 | 49.05K shares 10-K · filed 2023-03-01 | ||
| 2022-09-30 | 39.05K shares 10-Q · filed 2022-11-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| LENSAR, Inc. (LNSR) | United States | $0.087B | 2.02 |
| Microbot Medical Inc. (MBOT) | $0.089B | -7.97 | |
| Pulmonx Corp (LUNG) | United States | $0.082B | -1.16 |
| RenovoRx, Inc. (RNXT) | United States | $0.076B | -3.62 |
| FRACTYL HEALTH, INC. (GUTS) | United States | $0.075B | -1.18 |
| CVRx, Inc. (CVRX) | United States | $0.067B | -2.62 |
| DarioHealth Corp. (DRIO) | $0.066B | -1.39 | |
| TELA Bio, Inc. (TELA) | United States | $0.057B | -0.82 |
| Xtant Medical Holdings, Inc. (XTNT) | United States | $0.053B | |
| Apyx Medical Corp (APYX) | United States | $0.120B | -21.85 |